DK1572217T3 - Kombinationsmedikament af R,R-formoterol og ciclesonid - Google Patents

Kombinationsmedikament af R,R-formoterol og ciclesonid

Info

Publication number: DK1572217T3
Authority: DK; Denmark
Prior art keywords: ciclesonide; formoterol; combination drug; salt; combination
Prior art date: 2002-12-12

Application number

DK03789217T

Other languages

English (en)

Inventor

Klaus Dietzel

Degenhard Marx

Helgert Mueller

Christian Weimar

Original Assignee

Nycomed Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-12-12

Filing date

2003-12-11

Publication date

2008-12-15

2003-12-11 Application filed by Nycomed Gmbh filed Critical Nycomed Gmbh

2008-12-15 Application granted granted Critical

2008-12-15 Publication of DK1572217T3 publication Critical patent/DK1572217T3/da

Links

LUKZNWIVRBCLON-GXOBDPJESA-N Ciclesonide Chemical compound C1([C@H]2O[C@@]3([C@H](O2)C[C@@H]2[C@@]3(C[C@H](O)[C@@H]3[C@@]4(C)C=CC(=O)C=C4CC[C@H]32)C)C(=O)COC(=O)C(C)C)CCCCC1 LUKZNWIVRBCLON-GXOBDPJESA-N 0.000 title abstract 2
BPZSYCZIITTYBL-YJYMSZOUSA-N R-Formoterol Chemical compound C1=CC(OC)=CC=C1C[C@@H](C)NC[C@H](O)C1=CC=C(O)C(NC=O)=C1 BPZSYCZIITTYBL-YJYMSZOUSA-N 0.000 title abstract 2
229960003728 ciclesonide Drugs 0.000 title abstract 2
229940000425 combination drug Drugs 0.000 title 1
150000003839 salts Chemical class 0.000 abstract 2

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Pulmonology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
Glass Compositions (AREA)

DK03789217T 2002-12-12 2003-12-11 Kombinationsmedikament af R,R-formoterol og ciclesonid DK1572217T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP02027797		2002-12-12
DE10306213		2003-02-13
PCT/EP2003/014045 WO2004052374A1 (en)	2002-12-12	2003-12-11	Combination medicament

Publications (1)

Publication Number	Publication Date
DK1572217T3 true DK1572217T3 (da)	2008-12-15

Family

ID=32509778

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK03789217T DK1572217T3 (da)	2002-12-12	2003-12-11	Kombinationsmedikament af R,R-formoterol og ciclesonid

Country Status (15)

Country	Link
US (2)	US7879833B2 (da)
EP (1)	EP1572217B1 (da)
JP (1)	JP4755495B2 (da)
AT (1)	ATE405275T1 (da)
AU (1)	AU2003293833B2 (da)
CA (1)	CA2508692C (da)
DE (1)	DE60323138D1 (da)
DK (1)	DK1572217T3 (da)
ES (1)	ES2312844T3 (da)
HR (1)	HRP20050611B1 (da)
IS (1)	IS2597B (da)
PL (1)	PL375819A1 (da)
PT (1)	PT1572217E (da)
RS (1)	RS51707B (da)
WO (1)	WO2004052374A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8025896B2 (en)	2001-07-16	2011-09-27	Depuy Products, Inc.	Porous extracellular matrix scaffold and method
GB0312148D0 (en)	2003-05-28	2003-07-02	Aventis Pharma Ltd	Stabilized pharmaceutical products
EP1635845A1 (en)	2003-06-13	2006-03-22	ALTANA Pharma AG	Formoterol and ciclesonide combination
GB0315889D0 (en)	2003-07-08	2003-08-13	Aventis Pharma Ltd	Stable pharmaceutical products
US8371292B2 (en)	2003-09-16	2013-02-12	Nycomed Gmbh	Use of ciclesonide for the treatment of respiratory diseases
EP1796679A1 (en) *	2004-09-10	2007-06-20	Altana Pharma AG	Ciclesonide and syk inhibitor combination and methods of use thereof
WO2011093814A2 (en) *	2010-01-29	2011-08-04	Mahmut Bilgic	A pharmaceutical combination comprising formoterol and ciclesonide
MX2013004137A (es)	2010-10-12	2013-07-29	Cipla Ltd	Composicion farmaceutica.

Family Cites Families (79)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE9716T1 (de)	1980-02-27	1984-10-15	Tate & Lyle Public Limited Company	Kristalline glukose und verfahren zu deren herstellung.
US4816445A (en)	1984-06-21	1989-03-28	Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo	Crystalline alpha-maltose
JP2518646B2 (ja)	1987-05-29	1996-07-24	株式会社林原生物化学研究所	マルト−ス粉末の製造方法
US5133974A (en)	1989-05-05	1992-07-28	Kv Pharmaceutical Company	Extended release pharmaceutical formulations
ES2060040T5 (es)	1989-05-31	1999-09-16	Fisons Plc	Dispositivo y formulacion de inhalacion de medicamento.
IL95590A (en)	1989-09-08	1996-06-18	Glaxo Group Ltd	Medicinal preparations containing Salmetrol and Pluticasone Propionate
ATE92762T1 (de)	1989-09-08	1993-08-15	Glaxo Group Ltd	Medikamente.
SE8903914D0 (sv)	1989-11-22	1989-11-22	Draco Ab	Oral composition for the treatment of inflammatory bowel diseases
US6536427B2 (en)	1990-03-02	2003-03-25	Glaxo Group Limited	Inhalation device
US5178866A (en)	1990-03-23	1993-01-12	Alza Corporation	Dosage form for delivering drug to the intestine
JP2611073B2 (ja) *	1990-07-26	1997-05-21	モンサントカンパニー	新規ポリアミンの製造方法
GR1001529B (el)	1990-09-07	1994-03-31	Elmuquimica Farm Sl	Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.
US5434304A (en)	1990-09-26	1995-07-18	Aktiebolaget Astra	Process for preparing formoterol and related compounds
AU650953B2 (en)	1991-03-21	1994-07-07	Novartis Ag	Inhaler
US5795564A (en)	1991-04-05	1998-08-18	Sepracor, Inc.	Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
US6866839B2 (en)	1991-04-05	2005-03-15	Sepracor Inc.	Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
ES2200771T3 (es)	1991-06-10	2004-03-16	Schering Corporation	Formulaciones en aerosol no clorofluorocarbonadas.
IT1250691B (it)	1991-07-22	1995-04-21	Giancarlo Santus	Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac.
SG48301A1 (en)	1991-12-18	1998-04-17	Astra Ab	New combination
GB9213874D0 (en)	1992-06-30	1992-08-12	Fisons Plc	Process to novel medicament form
GB9306703D0 (en)	1993-03-31	1993-05-26	Fisons Plc	Inhalation device
ATE172739T1 (de)	1993-04-02	1998-11-15	Byk Gulden Lomberg Chem Fab	Neue prednisolonderivate
IL111194A (en)	1993-10-08	1998-02-08	Fisons Plc	Process for the production of medicament formulations
DE19541689A1 (de)	1994-11-14	1996-05-15	Byk Gulden Lomberg Chem Fab	Kombinationsarzneimittel
US5811388A (en)	1995-06-07	1998-09-22	Cibus Pharmaceutical, Inc.	Delivery of drugs to the lower GI tract
WO1996041626A1 (en)	1995-06-12	1996-12-27	G.D. Searle & Co.	Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor
EP0852498A1 (en)	1995-09-26	1998-07-15	Takeda Chemical Industries, Ltd.	Phosphorylamides, their preparation and use
DE19635498A1 (de)	1996-09-03	1998-03-26	Byk Gulden Lomberg Chem Fab	Verfahren zur Epimerenanreicherung
US6380222B2 (en)	1996-10-11	2002-04-30	Astrazeneca Ab	Use of an H+, K+-atpase inhibitor in the treatment of nasal polyps
SE9603725D0 (sv)	1996-10-11	1996-10-11	Astra Ab	New teatment
FR2754712B1 (fr)	1996-10-17	1999-09-03	Merck Sharp Dohme Chibret Lab	Compositions ophtalmiques
US6040344A (en)	1996-11-11	2000-03-21	Sepracor Inc.	Formoterol process
EP0938467B1 (en)	1996-11-11	2002-06-12	Sepracor, Inc.	Process for the preparation of optically pure isomers of formoterol
US6613795B2 (en)	1996-11-11	2003-09-02	Christian Noe	Enantiomerically pure basic arylcycloalkylhydroxycarboxylic esters, processes for their preparation and their use in medicaments
SE9700135D0 (sv)	1997-01-20	1997-01-20	Astra Ab	New formulation
US20020111495A1 (en) *	1997-04-04	2002-08-15	Pfizer Inc.	Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
US6120752A (en)	1997-05-21	2000-09-19	3M Innovative Properties Company	Medicinal aerosol products containing formulations of ciclesonide and related steroids
GB2329939A (en)	1997-06-26	1999-04-07	Glaxo Group Ltd	Self-lubricating valve stem for aerosol containers
US6470894B2 (en)	1997-09-19	2002-10-29	Thione International, Inc.	Glutathione, green tea, grape seed extract to neutralize tobacco free radicals
CA2301569A1 (en)	1997-10-08	1999-04-15	Martin P. Redmon	Dosage form for aerosol administration
SE9704186D0 (sv)	1997-11-14	1997-11-14	Astra Ab	New composition of matter
AU1507199A (en)	1997-12-15	1999-07-05	Yamanouchi Pharmaceutical Co., Ltd.	Novel pyrimidine-5-carboxamide derivatives
SE9801368D0 (sv)	1998-04-20	1998-04-20	Astra Ab	New use
TWI243687B (en)	1998-04-21	2005-11-21	Teijin Ltd	Pharmaceutical composition for application to mucosa
US6241969B1 (en)	1998-06-26	2001-06-05	Elan Corporation Plc	Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
ATE283033T1 (de)	1998-07-24	2004-12-15	Jago Res Ag	Medizinische aerosolformulierungen
EP1102579B1 (de) *	1998-08-04	2003-03-19	Jago Research Ag	Medizinische aerosolformulierungen
US6436953B1 (en)	1998-09-23	2002-08-20	Byk Gulden Lomberg Chemische Fabrik Gmbh	Tetrahydropyridoethers
DK1283036T3 (da)	1998-11-13	2008-03-25	Jagotec Ag	Törpulver til inhalation
US6352152B1 (en)	1998-12-18	2002-03-05	Smithkline Beecham Corporation	Method and package for storing a pressurized container containing a drug
US6124268A (en)	1999-02-17	2000-09-26	Natreon Inc.	Natural antioxidant compositions, method for obtaining same and cosmetic, pharmaceutical and nutritional formulations thereof
JP2001048807A (ja)	1999-08-04	2001-02-20	Wakamoto Pharmaceut Co Ltd	難溶性薬物を水に溶解してなる製剤
DE19947234A1 (de)	1999-09-30	2001-04-05	Asta Medica Ag	Neue Kombination von Loteprednol und Antihistaminika
AR026073A1 (es)	1999-10-20	2002-12-26	Nycomed Gmbh	Composicion farmaceutica acuosa que contiene ciclesonida
AR026072A1 (es)	1999-10-20	2002-12-26	Nycomed Gmbh	Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
GB0002336D0 (en)	2000-02-01	2000-03-22	Glaxo Group Ltd	Medicaments
GB0009607D0 (en)	2000-04-18	2000-06-07	Glaxo Group Ltd	Medical compositions
GB0012261D0 (en)	2000-05-19	2000-07-12	Astrazeneca Ab	Novel process
GB0015043D0 (en)	2000-06-21	2000-08-09	Glaxo Group Ltd	Medicament dispenser
FI20002177A0 (fi)	2000-10-02	2000-10-02	Orion Yhtymae Oyj	Uusi yhdistelmä astman hoitoon
US20020183292A1 (en)	2000-10-31	2002-12-05	Michel Pairet	Pharmaceutical compositions based on anticholinergics and corticosteroids
DE10062712A1 (de)	2000-12-15	2002-06-20	Boehringer Ingelheim Pharma	Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
US6528527B2 (en)	2000-11-07	2003-03-04	Merck & Co., Inc.	Method of treatment with a combination of a PDE4 inhibitor and a leukotriene antagonist
NZ526564A (en)	2000-12-22	2004-12-24	Glaxo Group Ltd	Metered dose inhaler for salmeterol xinafoate
WO2002062317A2 (en)	2001-02-06	2002-08-15	Innovata Biomed Limited	Bimodal dry powder formulation for inhalation
US20030055026A1 (en)	2001-04-17	2003-03-20	Dey L.P.	Formoterol/steroid bronchodilating compositions and methods of use thereof
WO2003006310A1 (fr)	2001-07-13	2003-01-23	Tfe Techniques Et Fabrications Electroniques	Dispositif destine a indiquer acoustiquement a un plongeur equipe d'un scaphandre la pression de gaz de respiration dans le reservoir et/ou la pression hydrostatique
JP2005508220A (ja)	2001-10-24	2005-03-31	パーリ・ゲーエムベーハー	薬用組成物調製用具
RU2326699C2 (ru)	2001-11-17	2008-06-20	Авентис Фарма Лимитед	Адсорбенты и их применение
US20050020637A1 (en)	2001-11-19	2005-01-27	Wolfgang-Alexander Simon	Agents for the treatment of airway disorders
GB0207899D0 (en) *	2002-04-05	2002-05-15	3M Innovative Properties Co	Formoterol and cielesonide aerosol formulations
ITMI20020808A1 (it)	2002-04-17	2003-10-17	Chiesi Farma Spa	Procedimento per la preparazione di una sospensione sterile di particelle di beclometasone dipropionato da somministrare per inalazione
MXPA04012756A (es)	2002-07-02	2005-03-23	Altana Pharma Ag	Suspension acuosa esteril que contiene ciclesonida.
PL373433A1 (en)	2002-08-30	2005-08-22	Altana Pharma Ag	The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis
US20060293293A1 (en)	2003-05-22	2006-12-28	Altana Pharma Ag	Salmeterol and ciclesonide combination
GB0312148D0 (en)	2003-05-28	2003-07-02	Aventis Pharma Ltd	Stabilized pharmaceutical products
EP1635845A1 (en)	2003-06-13	2006-03-22	ALTANA Pharma AG	Formoterol and ciclesonide combination
GB0315889D0 (en)	2003-07-08	2003-08-13	Aventis Pharma Ltd	Stable pharmaceutical products
US8371292B2 (en)	2003-09-16	2013-02-12	Nycomed Gmbh	Use of ciclesonide for the treatment of respiratory diseases

2003
- 2003-12-11 PT PT03789217T patent/PT1572217E/pt unknown
- 2003-12-11 JP JP2005502319A patent/JP4755495B2/ja not_active Expired - Lifetime
- 2003-12-11 CA CA2508692A patent/CA2508692C/en not_active Expired - Fee Related
- 2003-12-11 AU AU2003293833A patent/AU2003293833B2/en not_active Expired
- 2003-12-11 PL PL03375819A patent/PL375819A1/xx not_active Application Discontinuation
- 2003-12-11 EP EP03789217A patent/EP1572217B1/en not_active Expired - Lifetime
- 2003-12-11 US US10/537,356 patent/US7879833B2/en not_active Expired - Lifetime
- 2003-12-11 WO PCT/EP2003/014045 patent/WO2004052374A1/en not_active Ceased
- 2003-12-11 ES ES03789217T patent/ES2312844T3/es not_active Expired - Lifetime
- 2003-12-11 AT AT03789217T patent/ATE405275T1/de active
- 2003-12-11 RS YU20050429A patent/RS51707B/sr unknown
- 2003-12-11 HR HRP20050611AA patent/HRP20050611B1/hr not_active IP Right Cessation
- 2003-12-11 DE DE60323138T patent/DE60323138D1/de not_active Expired - Lifetime
- 2003-12-11 DK DK03789217T patent/DK1572217T3/da active
2005
- 2005-06-23 IS IS7910A patent/IS2597B/is unknown
2010
- 2010-12-20 US US12/973,350 patent/US8258124B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
AU2003293833A1 (en)	2004-06-30
JP4755495B2 (ja)	2011-08-24
US20110086827A1 (en)	2011-04-14
ATE405275T1 (de)	2008-09-15
PT1572217E (pt)	2008-11-28
IS7910A (is)	2005-06-23
US8258124B2 (en)	2012-09-04
EP1572217B1 (en)	2008-08-20
CA2508692C (en)	2012-04-03
JP2006514686A (ja)	2006-05-11
CA2508692A1 (en)	2004-06-24
AU2003293833B2 (en)	2009-10-01
US7879833B2 (en)	2011-02-01
PL375819A1 (en)	2005-12-12
US20060025392A1 (en)	2006-02-02
HRP20050611B1 (hr)	2013-12-20
RS51707B (sr)	2011-10-31
WO2004052374A1 (en)	2004-06-24
DE60323138D1 (de)	2008-10-02
EP1572217A1 (en)	2005-09-14
IS2597B (is)	2010-03-15
HRP20050611A2 (en)	2006-09-30
ES2312844T3 (es)	2009-03-01
RS20050429A (sr)	2007-12-31

Publication	Publication Date	Title
DE602004026113D1 (de)	2010-04-29	Glp-1-verbindungen
DE60327864D1 (de)	2009-07-16	Ballondissektor mit kanüle
NO20053974D0 (no)	2005-08-25	Tienopyrimidinforbindelser og anvendelse derav.
DK1534277T3 (da)	2012-01-09	Acylerede, heteroaryl-kondenserede cycloalkenylaminer og anvendelse af disse som lægemidler
CY1108808T1 (el)	2014-04-09	Ενωσεις μοτιλιδης
EP1863769A4 (en)	2009-03-18	HSP90 INHIBITORS, METHOD FOR THE PRODUCTION THEREOF AND THEIR APPLICATIONS
NO20044898L (no)	2005-02-25	Nye etonogestrel estere
DK1611884T3 (da)	2012-12-10	Plaster, indeholdende diclofenac
RU2002107079A (ru)	2003-11-20	Вещество, обладающее седативным действием
IS2597B (is)	2010-03-15	Lyf samsett úr R,R-formóteróli og siklesóníði
ITRM20020305A1 (it)	2003-12-01	Camptotecine con anello lattonico modificato.
DE60319388D1 (de)	2008-04-10	C6- UND C9-SUBSTITUIERTE CHROMENOÄ4,3-cÜISOXAZOLIN
EA200501088A1 (ru)	2005-12-29	Цетилпиридиниевая соль противоспалительного средства и фармацевтические композиции, содержащие ее
NO20061944L (no)	2006-05-02	Ny assosiasjon av et antiaterotrombotisk middel og et antiplateaggregerede middel
RU2002117643A (ru)	2004-03-27	Люплатекс, обладающий противолучевыми свойствами
TW200510461A (en)	2005-03-16	Disialoundecaglycosylasparagine - fatty acid amide and medicine containing the same
DK1592417T3 (da)	2007-08-06	Kombinationen af antidiabetiske lægemidler
NO20050781L (no)	2005-02-14	Cefalosporiner
PT1358182E (pt)	2004-12-31	Derivados de diazocinas e sua utilizacao como inibidores de triptase
ES1051002Y (es)	2002-10-16	Jeringa perfeccionada.
ITRM20030440A0 (it)	2003-09-24	Sistema d'indicazione temporale, in particolare dell'orario.
ITVR20030025A1 (it)	2004-09-07	Ortesi polso-dito.
ES1053443Y (es)	2003-08-01	Pijama perfeccionado.
RU2002131660A (ru)	2004-05-20	Антидот
ITRN20030033A1 (it)	2005-04-17	Apparato centratore con correzione diottrica e relativo procedimento.